EU OKs low-dose Xarelto to prevent recurrent VTE

2nd November 2017 Uncategorised 0

A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients.

More: EU OKs low-dose Xarelto to prevent recurrent VTE
Source: News